FDA Investigator Tammara A Stephens
Tammara A Stephens has inspections in 2 countries as of 29 Aug 2023. Tammara A Stephens has collaborated with a combined 2467 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
A Williams,
Adam R Cooke,
Amy H Ruble,
Arie C Menachem,
Babatunde D Babalola,
Barbara M Frazier,
Barbara T Carmichael,
Billy M Battles,
Bonita S Chester,
Brandon C Heitmeier,
Brandy D Brown,
Brentley S Collins,
Brooke K Higgins,
Burnell M Henry,
Calvin Foulks,
Carlos M Gonzalez,
CDR Ileana Barreto Pettit,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Cherry R Valerio,
Christian D Lynch (CDL),
Christie A Beatty,
Christie B Rice,
Christopher B May,
Claire M Minden,
Claudette D Brooks,
Cordelia J Brammer,
Cynthia Jim, CSO,
Daphne Santiago, PhD,
David J Gomes,
Dawn M Braswell,
Dellarese L Herbert,
Denise M Digiulio,
Dennis Cantellops Paite,
Derek C Price,
Devaugh Edwards,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Edward Deberry,
Edward H Maticka,
Eliezar Ramos,
Erin C Hill,
Fulton A Varner,
Gabriel R Mclemore,
Gamal A Norton,
George J Flynn,
Geraldine D Sanders,
Geraldine Sanders,
Gideon N Esuzor,
Hector A Carrero,
Helen R Bester,
Ibad U Khan,
Inga M Warr,
Jacqueline Mdiaz Albertini,
Jared P Stevens,
Jason F Chancey,
Jawaid Hamid,
Jennifer D Hollstrom,
Jennifer L Bridgewater,
Jennifer Lalama,
Joanne E King,
Joseph F Owens,
Julie D Bringger,
Justin A Boyd,
Karen A Coleman,
Karen Gale Sego,
Kathleen D Culver,
Katrina B Mosley Sloan,
Kimberly Cdelk Brooks,
Kip J Hanks,
Laiza V Garcia,
Larry K Hampton,
Latonya T Jiggetts,
Lawrence Carter, III,
Lesley K Satterwhite,
Leslie W Gilbert,
LT Tamara J Henderson,
Marc A Alston,
Marian A Kainer,
Marie F Morin,
Marisa E Stock,
Marvin D Jones,
Mary A Millner,
Mary Alice Papdimitriou,
Melanie M Walker,
Miaja Umaedi,
Michele L Forster, PhD,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Monica Cburgos Garcia,
Myoshi M Francis,
Nancy G Schmidt,
Nydia E Colon,
Omotunde O Osunsanmi,
Pal S Mayasandra,
Patricia D Stahnke,
Patricia F Hudson,
Paul A Bonneau,
Penny H Mccarver,
Perry H Gambrell,
Phillip M Pontikos,
Prabhu P Raju,
R Edwadebey Deberry,
Randy L Clarida,
Regina T Brown,
Rhonda Alexander,
Robert C Coleman,
Ronnie E Jackson,
Rose M Ashley,
Rozelle G Smith,
Samantha J Bradley,
Samuel L Murray,
Sayeeda Hdabe,
Seneca D Toms,
Sixto M Mercado Rios,
Sonya M Edmonds,
Stephanie E Hubbard,
Stephen D Brown,
Steven C Madzo,
Steven D Dittert,
Tamara M Casselman,
Tamara M Felton,
Tamika D Cathey,
Tammara A Newberry,
Thomas J Arista,
Thomas R Withers,
Trang N Cox,
Trang P Nguyen,
Travis E Chapman,
Vanessa E Coulter,
Vicky C Stoakes,
Vincent M Williams,
Viviana Matta,
Xiomara Copeland,
Yun Wu, PhD,
Zhong Li, PhD
Tammara A Stephens's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2005 | EIR | Greer Laboratories, Inc. - EIR, 2005-03-03 |
September, 2014 | EIR | Patheon Manufacturing Services LLC - EIR, 2014-09-12 |
March, 2013 | FDA 483 | Hospira, Inc. - Form 483, 2013-03-01 |
October, 2012 | FDA 483 | Artivion, Inc - Form 483, 2012-10-16 |
March, 2014 | FDA 483 Response | Artivion, Inc - Form 483R, 2014-04-10 |
June, 2010 | FDA 483 | Bausch & Lomb Incorporated - Form 483, 2010-06-25 |
March, 2014 | FDA 483 | Artivion, Inc - Form 483, 2014-03-20 |
June, 2014 | EIR | Hospira, Inc. - EIR, 2014-06-13 |
March, 2005 | FDA 483 | Greer Laboratories, Inc. - Form 483, 2005-03-03 |
May, 2009 | FDA 483 | Cardinal Health 414, LLC - Form 483, 2009-05-15 |
August, 2007 | FDA 483 | Qualitest Pharmaceuticals - Form 483, 2007-08-08 |
September, 2014 | FDA 483 | Patheon Manufacturing Services LLC - Form 483, 2014-09-12 |
August, 2005 | FDA 483 | Artivion, Inc - Form 483, 2005-08-05 |
March, 2013 | EIR | Hospira, Inc. - EIR, 2013-03-01 |
August, 2018 | FDA 483 | Artivion, Inc - Form 483, 2018-08-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more